Effect of Repeat Sternotomy on Cardiac Surgery Outcomes

Research Article

Ann Surg Perioper Care. 2016; 1(1): 1001.

Effect of Repeat Sternotomy on Cardiac Surgery Outcomes

Lemaire A*, Batsides G, Saadat S, Ghaly A, Nishimura T, Volk L, Spotnitz A and Lee LY

Division of Cardiothoracic Surgery, Department of Surgery, RUTGERS-Robert Wood Johnson Medical School, 125 Paterson Street, New Brunswick, New Jersey, 08903, USA

*Corresponding author: Anthony Lemaire, Assistant Professor, Division of Cardiothoracic Surgery, Department of Surgery, RUTGERS-Robert Wood Johnson Medical School, 125 Paterson Street, New Brunswick, New Jersey, 08903, USA

Received: August 05, 2016; Accepted: September 02, 2016; Published: September 06, 2016

Abstract

Purpose: To determine the impact of repeat sternotomy after adult cardiac surgery on surgical outcomes. The primary endpoints include operative mortality and rate of reoperation for bleeding.

Methods: A retrospective review of prospectively collected data from a single institution. The patients underwent coronary artery bypass grafting (CABG), valvular surgery, CABG and valvular surgery and other procedures from July 1st, 2011 to December 31st, 2013. Charts were evaluated for demographics, operative details and postoperative outcomes. Operative mortality was defined as death within 30-days of surgery.

Results: We identified 165 patients who underwent 170 total adult cardiac surgery procedures. The average age of the patients was 68.93 ± 13.3 and the majority of the patients were male (N=116). The patient’s original surgical procedures were predominantly CABG (39%), with the remaining patients having undergone valvular surgery (26%), and other procedures (35%) including insertion of a left ventricular assist device (Figure 1). Of the redo-sternotomy procedures the majority of patients underwent valvular surgery (52%) either multiple valve procedures or combination of CABG and valvular surgery. The remaining patients had other procedures (37%) performed including orthotropic heart transplantation, and the rest underwent CABG (11%) (Figure 2). The mortality rate was 7% for the entire group with 4% mortality for aortic valve replacement (AVR), 3% for mitral valve procedures and 0% for CABG. The rate of reoperation for bleeding was 2.4% for the entire group with 1.9% for AVR, and 0% for CABG.